CDT Equity Inc. Common Stock (CDT)
Conduit Pharmaceuticals Inc. (CDT) is a biopharmaceutical company focused on developing innovative therapies for the treatment of inflammatory and autoimmune diseases. The company emphasizes research and development to create targeted medications aimed at improving patient outcomes in conditions such as rheumatoid arthritis and other chronic inflammatory disorders.
Company News
Conduit Pharmaceuticals has restructured a $2.65 million loan note with Nirland Limited, removing restrictive clauses and making the note convertible. The company has also secured $1.2 million in new promissory notes, positioning it to access its At-The-Market (ATM) facility to support its note repayment obligations, operations, and clinical objectives.
Bloom Energy shares jumped 12.1% after announcing a strategic partnership with CoreWeave to deploy its fuel cells for on-site power generation at a data center. Several other stocks also saw significant pre-market movements, both positive and negative.
The stock had a brief big rebound from a huge drop on Tuesday.